Norton Healthcare Foundation announced that it received a $125,000 grant from the PNC Foundation to assist it in supporting COVID-19 relief efforts in the community. The funds will be used to provide antibody testing as part of the Norton Healthcare Convalescent Plasma Program, make additional testing available for patients and provide meals for employees. “We’re…
Norton Healthcare specialists are researching a variety of experimental therapies as possible treatments for patients with COVID-19. These therapies fall into four categories: Agents that work to prevent the virus from growing: Medications are being used to either kill the virus or prevent it from growing. Drugs that block or lessen the profound inflammation that…
Physicians around the country are testing a possible treatment for COVID-19 using plasma taken from blood donated by fully recovered COVID-19 patients, called convalescent plasma. Locally, Norton Healthcare began offering this experimental treatment in early April and has transfused 21 patients who were critically ill with COVID-19. Of those, six have been well enough to…
A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm Therapeutics Inc. and marketed as XPOVIO, is currently approved at higher doses by the U.S. Food and Drug Administration (FDA) as a treatment for cancer patients…
Norton Healthcare physicians are testing a possible treatment for COVID-19 using convalescent plasma taken from blood donated by fully recovered COVID-19 patients. With approval from the U.S. Food and Drug Administration, Norton Healthcare is recruiting candidates to donate plasma that may contain coronavirus-fighting antibodies. As an experimental treatment, the initial convalescent plasma procedure is available…
When Brenda Montgomery enrolled in a clinical trial at Norton Cancer Institute in February 2016, she hoped the new drug being researched would trounce the cancer she had battled for nine years. She also hoped her efforts would help others. “Hearing you have cancer is like getting hit with a brick, but I’ve been determined…
The U.S. Food and Drug Administration recently approved a new cancer drug that has been available only to patients enrolled by a Norton Cancer Institute physician and one other researcher nationwide. Don A. Stevens, M.D., medical oncologist/hematologist and director of the Hematologic Malignancy Program at Norton Cancer Institute, was one of only two physicians in…